R Ohno

8.3k total citations · 1 hit paper
104 papers, 5.7k citations indexed

About

R Ohno is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, R Ohno has authored 104 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 41 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in R Ohno's work include Acute Myeloid Leukemia Research (37 papers), Acute Lymphoblastic Leukemia research (20 papers) and Retinoids in leukemia and cellular processes (18 papers). R Ohno is often cited by papers focused on Acute Myeloid Leukemia Research (37 papers), Acute Lymphoblastic Leukemia research (20 papers) and Retinoids in leukemia and cellular processes (18 papers). R Ohno collaborates with scholars based in Japan, United States and Italy. R Ohno's co-authors include T Naoe, Hidehiko Saito, Kazunori Ohnishi, John M. Bennett, Francesco Lo‐Coco, Cheryl L. Willman, Clara D. Bloomfield, Elihu H. Estey, Andrea Biondi and Tim Lister and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Heart Journal.

In The Last Decade

R Ohno

99 papers receiving 5.6k citations

Hit Papers

Revised Recommendations o... 2003 2026 2010 2018 2003 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R Ohno 4.1k 2.2k 1.3k 1.2k 1.1k 104 5.7k
E Archimbaud 3.3k 0.8× 2.3k 1.1× 1.1k 0.8× 1.4k 1.2× 616 0.5× 124 5.1k
Giuseppe Avvisati 5.0k 1.2× 4.1k 1.9× 987 0.8× 1.5k 1.3× 922 0.8× 202 7.5k
Andrew M. Yeager 2.8k 0.7× 996 0.5× 888 0.7× 899 0.8× 805 0.7× 91 4.5k
Adriano Venditti 3.6k 0.9× 2.1k 1.0× 1.2k 1.0× 1.0k 0.9× 1.4k 1.2× 259 5.6k
Giuseppe Visani 4.0k 1.0× 2.2k 1.0× 981 0.8× 1.4k 1.2× 2.0k 1.8× 285 6.6k
Vinod Pullarkat 3.8k 0.9× 1.9k 0.9× 1.3k 1.0× 1.2k 1.0× 1.4k 1.2× 228 6.0k
Pau Montesinos 3.8k 0.9× 2.8k 1.3× 996 0.8× 1.1k 1.0× 789 0.7× 309 5.3k
Felicetto Ferrara 3.9k 1.0× 2.6k 1.2× 1.6k 1.2× 1.1k 1.0× 1.0k 0.9× 196 5.7k
Stéphane de Botton 4.1k 1.0× 3.0k 1.4× 997 0.8× 1.2k 1.0× 1.3k 1.2× 201 6.2k
Arnaud Pigneux 2.8k 0.7× 1.4k 0.7× 973 0.8× 765 0.7× 869 0.8× 161 4.1k

Countries citing papers authored by R Ohno

Since Specialization
Citations

This map shows the geographic impact of R Ohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Ohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Ohno more than expected).

Fields of papers citing papers by R Ohno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Ohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Ohno. The network helps show where R Ohno may publish in the future.

Co-authorship network of co-authors of R Ohno

This figure shows the co-authorship network connecting the top 25 collaborators of R Ohno. A scholar is included among the top collaborators of R Ohno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Ohno. R Ohno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katsuda, Yousuke, R Ohno, Yasunobu Hasegawa, et al.. (2025). Staple oligomers induce a stable RNA G-quadruplex structure for protein translation inhibition in therapeutics. Nature Biomedical Engineering.
2.
Suzuki, Yuta, Hidehiro Kaneko, Akira Okada, et al.. (2023). Comparison of SGLT2 inhibitors vs. DPP4 inhibitors for patients with metabolic dysfunction associated fatty liver disease and diabetes mellitus. Journal of Endocrinological Investigation. 47(5). 1261–1270. 11 indexed citations
4.
Kiyoi, Hitoshi, K. Ozeki, T. Kinoshita, et al.. (2005). Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome. Leukemia. 19(8). 1367–1375. 32 indexed citations
5.
Cheson, Bruce D., John M. Bennett, Thomas Büchner, et al.. (2003). Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. Journal of Clinical Oncology. 21(24). 4642–4649. 1873 indexed citations breakdown →
6.
Ohno, R, Norio Asou, & Kazunori Ohnishi. (2003). Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia. 17(8). 1454–1463. 110 indexed citations
7.
Suzuki, Akitaka, Kazuma Ohyashiki, Yukihiko Kimura, et al.. (2000). Trisomy 11 acute myeloid leukemia: 5 additional cases from the Japan Adult Leukemia Study Group AML-92 and AML-95 databases.. PubMed. 72(4). 466–9. 2 indexed citations
9.
Takeshita, Akihiro, Kaori Shinjo, Miho Yamashita, et al.. (1999). Extensive cytogenetic studies of clonality following interferon-α therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic. Leukemia. 13(11). 1749–1753. 6 indexed citations
10.
Ohno, R. (1998). Multicenter cooperative study group in hematology in Japan: the 10-year history and role of the Japan Adult Leukemia Study Group in Japan.. PubMed. 67(3). 213–9. 1 indexed citations
11.
Oh, Hannah, Gale Rp, M-J Zhang, et al.. (1998). Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission. Bone Marrow Transplantation. 22(3). 253–257. 36 indexed citations
13.
Kiyoi, Hitoshi, K Naito, R Ohno, Hidehiko Saito, & T Naoe. (1998). Characterization of the immunoglobulin light chain variable region gene expressed in multiple myeloma. Leukemia. 12(4). 601–609. 9 indexed citations
14.
Mori, Hitoshi, Hitoshi Kiyoi, Keizo Horibe, R Ohno, & T Naoe. (1997). Comparison of the immunoglobulin gene transcripts between immature B lineage acute lymphoblastic leukemia and the normal phenotypic counterparts in the bone marrow. Leukemia. 11(8). 1274–1280. 4 indexed citations
15.
Tsuda, Hiroyuki, Kiyoshi Takatsuki, R Ohno, et al.. (1994). Treatment of adult T-cell leukaemia–lymphoma with irinotecan hydrochloride (CPT-11). British Journal of Cancer. 70(4). 771–774. 63 indexed citations
16.
Ohno, R, Toshiyuki Kobayashi, Y Morishima, et al.. (1992). Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).. PubMed. 6 Suppl 2. 92–5. 12 indexed citations
17.
Ohno, R, Kosuke Okada, T Masaoka, et al.. (1990). An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.. Journal of Clinical Oncology. 8(11). 1907–1912. 204 indexed citations
19.
Ohno, R, et al.. (1985). STUDY ON HARDNESS OF BUILDING FLOORS AND ITS METHOD OF EVALUATION FROM A VIEWPOINT OF COMFORTABLENESS : Part 1 The scaling of human senses on Hardness of building floors. Journal of Structural and Construction Engineering (Transactions of AIJ). 358(0). 1–9. 3 indexed citations
20.
Kato, Yasuhiro, et al.. (1978). Extraction and identification of leukemia associated antigen.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 41(6). 1163–70.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026